Skip to Content

Biopsy Reclassification Risk in Prostate Cancer Examined

FRIDAY, Nov. 20, 2020 -- Active surveillance for low-risk prostate cancer is associated with a low risk for cancer spread, according to a study published in the Dec. 1 issue of The Journal of Urology.

Peter E. Lonergan, M.D., from the University of California in San Francisco, and colleagues determined predictors of biopsy reclassification at specific time points among 1,031 men with clinically low-risk prostate cancer prospectively enrolled in active surveillance between 2000 and 2016.

The researchers found that biopsy reclassification was associated with prostate-specific antigen (PSA) density 0.15 or greater (hazard ratio [HR], 3.37), percentage biopsy cores positive (HR, 1.27), and high genomic score (HR, 2.81) at first surveillance biopsy as well as at one to three years, after adjusting for other factors. At three to five years, reclassification was associated with PSA density 0.15 or greater (HR, 2.36) and PSA kinetics (HR, 2.19). A Prostate Imaging Reporting and Data System score of 4 to 5 was not associated with biopsy reclassification at any time point. Overall, at seven years, 99 percent of patients were alive and without metastases.

"In the long-term, active surveillance is a safe and viable option for men with low-risk and carefully selected intermediate-risk prostate cancer," a coauthor said in a statement.

Abstract/Full Text (subscription or payment may be required)

© 2020 HealthDay. All rights reserved.

Posted: November 2020

Read this next

Job Changes Increasingly Common Among U.S. Radiologists

WEDNESDAY, Nov. 25, 2020 -- More than 40 percent of radiologists separated from at least one practice in recent years, according to a study published online Nov. 13 in the Journal...

AI Algorithm Can Detect COVID-19 on Chest X-Rays

WEDNESDAY, Nov. 25, 2020 -- An artificial intelligence (AI) algorithm can detect COVID-19 on chest X-rays with similar performance to that of a consensus of thoracic radiologists,...

Many Infants With Hep C-Positive Moms Not Screened for HCV

WEDNESDAY, Nov. 25, 2020 -- Less than one-third of infants born to mothers with hepatitis C virus infection (HCV+) receive appropriate HCV follow-up testing, according to a study...